Lynn Gellermann

Executive Director

John Glazer

Director

Faith Knutsen

Associate Director of Operations

Jane New

Manager of Investments and New Venture Development

Christin Tripp

Venture Analytics Associate

Past deals in Southeastern Europe

Stirling Ultracold

Series B in 2018
Stirling Ultracold, a division of Global Cooling, Inc., is a developer and manufacturer of a new generation of environmentally friendly ultra-low temperature freezers which operate below -86°C. These freezers do not use dry ice, Peltier or conventional cascade refrigeration systems. Instead, the Stirling Ultracold product line operates on free-piston Stirling engine technology.

Stirling Ultracold

Venture Round in 2016
Stirling Ultracold, a division of Global Cooling, Inc., is a developer and manufacturer of a new generation of environmentally friendly ultra-low temperature freezers which operate below -86°C. These freezers do not use dry ice, Peltier or conventional cascade refrigeration systems. Instead, the Stirling Ultracold product line operates on free-piston Stirling engine technology.

Promiliad

Seed Round in 2011
Promiliad Biopharma Inc. is a drug discovery company focused on creating natural product-like small molecules. Established in 2002 and headquartered in Alberton, Montana, the company specializes in producing bulk quantities of pure natural products and their derivatives, as well as arrayed libraries for high-throughput screening. Its research programs target pathogenic organisms, including gram-negative bacteria and the protozoal pathogen Cryptosporidium, which causes diarrheal diseases in humans. Promiliad employs a technology known as ReBACS, which enhances structural diversity and simplifies the synthetic challenges in drug discovery, thereby increasing the likelihood of developing new antibacterial and antifungal agents. Additionally, the company provides screening compounds in ready-to-use plates and offers ammonium selective ionophore nonactin for ammonia selective electrodes and biomedical research. Promiliad also conducts research at locations in Missoula, Montana, and Athens, Ohio.

Sanuthera

Seed Round in 2011
Sanuthera, Inc. designs and manufactures medical devices to treat patients with tinnitus and hearing loss disorder. The company was incorporated in 2011 and is based in Athens, Ohio.